BAKEWELL JOHN K 4

What Happened
John K. Bakewell, a director of Treace Medical Concepts, Inc. (TMCI), was granted 30,000 restricted stock units (RSUs) on 2026-05-19 (transaction code A). The RSUs were granted at $0.00 per unit (total reported value $0.00) — this is an equity award, not a purchase or sale.

Key Details

• Transaction date: 2026-05-19; transaction type: Award/Grant (code A).
• Quantity: 30,000 RSUs; reported acquisition price: $0.00; reported value: $0.00.
• Shares owned after transaction: Not specified in the filing.
• Footnotes:
  • F1: Each RSU converts to one share upon vesting. The RSUs vest 100% on the earlier of (a) May 19, 2027 or (b) the 2027 annual meeting of stockholders, subject to continued service. The reporting person elected to defer receipt of the underlying shares until the earlier of a change in control, separation of service, or the fifth anniversary of the grant.
  • F2: Confirms the 30,000 RSUs referenced.
• Filing timeliness: Reported with a period of report matching the transaction date (no late filing indicated).

Context
RSUs are a form of compensation, converting to common shares only when they vest; because the reporting person has deferred receipt, no shares may be issued to him immediately. Awards are common for directors and executives as compensation and do not by themselves indicate buying or selling sentiment.